eCite Digital Repository

Targeting renin-angiotensin system against Alzheimer's Disease

Citation

Gebre, AK and Altaye, BM and Atey, TM and Tuem, KB and Berhe, DF, Targeting renin-angiotensin system against Alzheimer's Disease, Frontiers in Pharmacology, 9 pp. 1-11. ISSN 1663-9812 (2018) [Refereed Article]


Preview
PDF (Published version)
590Kb
  

Copyright Statement

Copyright 2018 Gebre, Altaye, Atey, Tuem and Berhe. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/).

DOI: doi:10.3389/fphar.2018.00440

Abstract

Renin Angiotensin System (RAS) is a hormonal system that regulates blood pressure and fluid balance through a coordinated action of renal, cardiovascular, and central nervous systems. In addition to its hemodynamic regulatory role, RAS involves in many brain activities, including memory acquisition and consolidation. This review has summarized the involvement of RAS in the pathology of Alzheimer's disease (AD), and the outcomes of treatment with RAS inhibitors. We have discussed the effect of brain RAS in the amyloid plaque (Aβ) deposition, oxidative stress, neuroinflammation, and vascular pathology which are directly and indirectly associated with AD. Angiotensin II (AngII) via AT1 receptor is reported to increase brain Aβ level via different mechanisms including increasing amyloid precursor protein (APP) mRNA, β-secretase activity, and presenilin expression. Similarly, it was associated with tau phosphorylation, and reactive oxygen species generation. However, these effects are counterbalanced by Ang II mediated AT2 signaling. The protective effect observed with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) could be as the result of inhibition of Ang II signaling. ARBs also offer additional benefit by shifting the effect of Ang II toward AT2 receptor. To conclude, targeting RAS in the brain may benefit patients with AD though it still requires further in depth understanding.

Item Details

Item Type:Refereed Article
Keywords:ACEI, AD, ARB, RAS, amyloid β, inflammation, oxidative stress, vascular disease
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacy and pharmacy practice
Objective Division:Manufacturing
Objective Group:Human pharmaceutical products
Objective Field:Human pharmaceutical treatments
UTAS Author:Atey, TM (Mr Tesfay Atey)
ID Code:146001
Year Published:2018
Web of Science® Times Cited:50
Deposited By:Pharmacy
Deposited On:2021-08-17
Last Modified:2021-09-08
Downloads:14 View Download Statistics

Repository Staff Only: item control page